Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer

Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer

Even though immune checkpoint inhibitors (ICIs) are effective on multiple cancer types, there are still many non-responding patients. A possible factor put forward that may influence the efficacy of ICIs is the gut microbiota. Additionally, faecal microbiota transplantation may enhance efficacy of I...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of gastroenterology : WJG 2021-08, Vol.27 (32), p.5362-5375
Hauptverfasser: Kang, Yong-Bo, Cai, Yue
Format: Artikel
Sprache:eng
Schlagworte:
Minireviews
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5375
container_issue 32
container_start_page 5362
container_title World journal of gastroenterology : WJG
container_volume 27
creator Kang, Yong-Bo
Cai, Yue
description Even though immune checkpoint inhibitors (ICIs) are effective on multiple cancer types, there are still many non-responding patients. A possible factor put forward that may influence the efficacy of ICIs is the gut microbiota. Additionally, faecal microbiota transplantation may enhance efficacy of ICIs. Nevertheless, the data available in this field are insufficient, and relevant scientific work has just commenced. As a result, the current work reviewed the latest research on the association of gut microbiota with ICI treatments based on anti-programmed cell death protein 1 antibody and anti- cytotoxic T-lymphocyte-associated protein 4 antibody and explored the therapeutic potential of faecal microbiota transplantation in combination with ICI therapy in the future.
doi_str_mv 10.3748/wjg.v27.i32.5362
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8409158</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2574742444</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-5cc4a399095f829ad4a7dc9278c6c597339c6371b0fcbce692e4b08381d845933</originalsourceid><addsrcrecordid>eNpVkTFvFDEQhS0EIpdAT-mSZg-vxz7bDRKKCCBFSgO15Z3z3vrYtRfbF3T_Pj4lQqKaYt57o3kfIR96tgUl9Ke_x8P2kattAL6VsOOvyIbz3nRcC_aabHrGVGeAqytyXcqRMQ4g-VtyBUKC6UFvyPHOeXQzXQLmNIRUHa3ZxbLOLlZXQ4rUx8lF9IX6cQzo8EzTSMOynKKnOHn8vaYQKw1xCkOoKRdaJ5_deqbu4EIsleLFn9-RN6Obi3__Mm_Ir7uvP2-_d_cP337cfrnvEBTUTiIKB8YwI0fNjdsLp_ZouNK4Q2kUgMEdqH5gIw7od4Z7MTANut9rIQ3ADfn8nLuehsXv0cf20WzXHBaXzza5YP_fxDDZQ3q0rTTTS90CPr4E5PTn5Eu1Syjo51aJT6diuVRCCS6EaFL2LG3tlZL9-O9Mz-wFkW2IbENkGyJ7QQRPRaiHoQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2574742444</pqid></control><display><type>article</type><title>Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer</title><source>Baishideng "World Journal of" online journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Kang, Yong-Bo ; Cai, Yue</creator><creatorcontrib>Kang, Yong-Bo ; Cai, Yue</creatorcontrib><description>Even though immune checkpoint inhibitors (ICIs) are effective on multiple cancer types, there are still many non-responding patients. A possible factor put forward that may influence the efficacy of ICIs is the gut microbiota. Additionally, faecal microbiota transplantation may enhance efficacy of ICIs. Nevertheless, the data available in this field are insufficient, and relevant scientific work has just commenced. As a result, the current work reviewed the latest research on the association of gut microbiota with ICI treatments based on anti-programmed cell death protein 1 antibody and anti- cytotoxic T-lymphocyte-associated protein 4 antibody and explored the therapeutic potential of faecal microbiota transplantation in combination with ICI therapy in the future.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v27.i32.5362</identifier><identifier>PMID: 34539138</identifier><language>eng</language><publisher>Baishideng Publishing Group Inc</publisher><subject>Minireviews</subject><ispartof>World journal of gastroenterology : WJG, 2021-08, Vol.27 (32), p.5362-5375</ispartof><rights>The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. 2021</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c373t-5cc4a399095f829ad4a7dc9278c6c597339c6371b0fcbce692e4b08381d845933</citedby><cites>FETCH-LOGICAL-c373t-5cc4a399095f829ad4a7dc9278c6c597339c6371b0fcbce692e4b08381d845933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409158/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409158/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Kang, Yong-Bo</creatorcontrib><creatorcontrib>Cai, Yue</creatorcontrib><title>Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer</title><title>World journal of gastroenterology : WJG</title><description>Even though immune checkpoint inhibitors (ICIs) are effective on multiple cancer types, there are still many non-responding patients. A possible factor put forward that may influence the efficacy of ICIs is the gut microbiota. Additionally, faecal microbiota transplantation may enhance efficacy of ICIs. Nevertheless, the data available in this field are insufficient, and relevant scientific work has just commenced. As a result, the current work reviewed the latest research on the association of gut microbiota with ICI treatments based on anti-programmed cell death protein 1 antibody and anti- cytotoxic T-lymphocyte-associated protein 4 antibody and explored the therapeutic potential of faecal microbiota transplantation in combination with ICI therapy in the future.</description><subject>Minireviews</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkTFvFDEQhS0EIpdAT-mSZg-vxz7bDRKKCCBFSgO15Z3z3vrYtRfbF3T_Pj4lQqKaYt57o3kfIR96tgUl9Ke_x8P2kattAL6VsOOvyIbz3nRcC_aabHrGVGeAqytyXcqRMQ4g-VtyBUKC6UFvyPHOeXQzXQLmNIRUHa3ZxbLOLlZXQ4rUx8lF9IX6cQzo8EzTSMOynKKnOHn8vaYQKw1xCkOoKRdaJ5_deqbu4EIsleLFn9-RN6Obi3__Mm_Ir7uvP2-_d_cP337cfrnvEBTUTiIKB8YwI0fNjdsLp_ZouNK4Q2kUgMEdqH5gIw7od4Z7MTANut9rIQ3ADfn8nLuehsXv0cf20WzXHBaXzza5YP_fxDDZQ3q0rTTTS90CPr4E5PTn5Eu1Syjo51aJT6diuVRCCS6EaFL2LG3tlZL9-O9Mz-wFkW2IbENkGyJ7QQRPRaiHoQ</recordid><startdate>20210828</startdate><enddate>20210828</enddate><creator>Kang, Yong-Bo</creator><creator>Cai, Yue</creator><general>Baishideng Publishing Group Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210828</creationdate><title>Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer</title><author>Kang, Yong-Bo ; Cai, Yue</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-5cc4a399095f829ad4a7dc9278c6c597339c6371b0fcbce692e4b08381d845933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Minireviews</topic><toplevel>online_resources</toplevel><creatorcontrib>Kang, Yong-Bo</creatorcontrib><creatorcontrib>Cai, Yue</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kang, Yong-Bo</au><au>Cai, Yue</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><date>2021-08-28</date><risdate>2021</risdate><volume>27</volume><issue>32</issue><spage>5362</spage><epage>5375</epage><pages>5362-5375</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>Even though immune checkpoint inhibitors (ICIs) are effective on multiple cancer types, there are still many non-responding patients. A possible factor put forward that may influence the efficacy of ICIs is the gut microbiota. Additionally, faecal microbiota transplantation may enhance efficacy of ICIs. Nevertheless, the data available in this field are insufficient, and relevant scientific work has just commenced. As a result, the current work reviewed the latest research on the association of gut microbiota with ICI treatments based on anti-programmed cell death protein 1 antibody and anti- cytotoxic T-lymphocyte-associated protein 4 antibody and explored the therapeutic potential of faecal microbiota transplantation in combination with ICI therapy in the future.</abstract><pub>Baishideng Publishing Group Inc</pub><pmid>34539138</pmid><doi>10.3748/wjg.v27.i32.5362</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2021-08, Vol.27 (32), p.5362-5375
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8409158
source Baishideng "World Journal of" online journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Minireviews
title Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T11%3A10%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Faecal%20microbiota%20transplantation%20enhances%20efficacy%20of%20immune%20checkpoint%20inhibitors%20therapy%20against%20cancer&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Kang,%20Yong-Bo&rft.date=2021-08-28&rft.volume=27&rft.issue=32&rft.spage=5362&rft.epage=5375&rft.pages=5362-5375&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v27.i32.5362&rft_dat=%3Cproquest_pubme%3E2574742444%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2574742444&rft_id=info:pmid/34539138&rfr_iscdi=true